Postoperative Crohn's disease

Inflamm Bowel Dis. 2005 Aug;11(8):765-77. doi: 10.1097/01.mib.0000171273.09757.f2.

Abstract

More than three quarters of patients with Crohn's disease (CD) will require surgery. After resection, disease recurs postoperatively with a median time to second resection of about 10 years. Despite its importance, the postoperative period remains one of the most poorly understood clinical settings in the field. Postoperatively, CD may exhibit unique pathophysiologic features, but the current state of knowledge does not allow for identification of patients at risk for relapse, and leaves clinicians without guidance on optimal maintenance treatment. Therapies used as maintenance for CD in other settings may have different efficacies when used after surgery, and clinical research in patients requiring surgery is limited by the subset of patients available for study. Despite the many limitations in current knowledge of postoperative CD, it is an exciting field because new developments have improved patient care, and ongoing research has the potential for further gains.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Colectomy / adverse effects
  • Colectomy / methods*
  • Colonoscopy
  • Crohn Disease / drug therapy
  • Crohn Disease / pathology*
  • Crohn Disease / surgery*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Male
  • Postoperative Complications / drug therapy
  • Postoperative Complications / pathology
  • Postoperative Complications / surgery*
  • Probiotics / therapeutic use
  • Prognosis
  • Reoperation / statistics & numerical data
  • Risk Assessment
  • Secondary Prevention
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents